Finally, the total area of vessels (CD31+ area) remained unaffected (Figure 2D, 2I), suggesting that Pirfenidone, at the selected dose of 500 mg/kg, did not affect tumor angiogenesis. Here, PECAM1 is linked to neoplasm.